Reporting a loss generally has a negative impact on investor sentiment and can lead to a decrease in stock price in the short term. Given that this is a quarterly earnings report, it is directly relevant and important to investors of AEON Biopharma. The confidence in this analysis is high due to the straightforward nature of earnings reports' impact on stock prices.